These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 35078986)

  • 1. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
    Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
    Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The length of guide RNA and target DNA heteroduplex effects on CRISPR/Cas9 mediated genome editing efficiency in porcine cells.
    Lv J; Wu S; Wei R; Li Y; Jin J; Mu Y; Zhang Y; Kong Q; Weng X; Liu Z
    J Vet Sci; 2019 May; 20(3):e23. PubMed ID: 31161741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
    Mekler V; Kuznedelov K; Severinov K
    J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants for Efficient Editing with Cas9-Mediated Recombineering in
    Choudhury A; Fankhauser RG; Freed EF; Oh EJ; Morgenthaler AB; Bassalo MC; Copley SD; Kaar JL; Gill RT
    ACS Synth Biol; 2020 May; 9(5):1083-1099. PubMed ID: 32298586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multiplexed CRISPR/Cas9 Editing System Based on the Endogenous tRNA Processing.
    Xie K; Yang Y
    Methods Mol Biol; 2019; 1917():63-73. PubMed ID: 30610628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gRNA validation for wheat genome editing with the CRISPR-Cas9 system.
    Arndell T; Sharma N; Langridge P; Baumann U; Watson-Haigh NS; Whitford R
    BMC Biotechnol; 2019 Oct; 19(1):71. PubMed ID: 31684940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P; Wolter F; Puchta H
    Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cleavage-Responsive Stem-Loop Hairpin for Assaying Guide RNA Activity.
    deBoer TR; Wauford N; Chung JY; Torres Perez MS; Murthy N
    ACS Chem Biol; 2018 Feb; 13(2):461-466. PubMed ID: 29381046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters.
    Alkan F; Wenzel A; Anthon C; Havgaard JH; Gorodkin J
    Genome Biol; 2018 Oct; 19(1):177. PubMed ID: 30367669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Precise Genome Editing Using Donor DNA/gRNA Hybrid Duplex Generated by Complementary Bases.
    Aiba W; Amai T; Ueda M; Kuroda K
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing.
    Liu X; Xiong W; Qi Q; Zhang Y; Ji H; Cui S; An J; Sun X; Yin H; Tian T; Zhou X
    Nucleic Acids Res; 2022 May; 50(8):4769-4783. PubMed ID: 35446403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetically modified guide RNA and donor DNA are a versatile platform for CRISPR-Cas9 engineering.
    Lee K; Mackley VA; Rao A; Chong AT; Dewitt MA; Corn JE; Murthy N
    Elife; 2017 May; 6():. PubMed ID: 28462777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
    Wang Q; Ui-Tei K
    Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.
    Li Y; Zhang L; Yang H; Xia Y; Liu L; Chen X; Shen W
    Microbiol Spectr; 2022 Jun; 10(3):e0005922. PubMed ID: 35543560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Genome Editing with CRISPR-Cas9.
    Rahman S; Ikram AR; Azeem F; Tahir Ul Qamar M; Shaheen T; Mehboob-Ur-Rahman
    Methods Mol Biol; 2024; 2788():355-372. PubMed ID: 38656525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR Genome Editing Made Easy Through the CHOPCHOP Website.
    Labun K; Krause M; Torres Cleuren Y; Valen E
    Curr Protoc; 2021 Apr; 1(4):e46. PubMed ID: 33905612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.